Production (Stage)
Merck KGaA
MKGAF
$129.80
-$1.65-1.26%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.79% | -0.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.79% | -0.24% | |||
| Cost of Revenue | -7.56% | 4.18% | |||
| Gross Profit | -1.06% | -3.22% | |||
| SG&A Expenses | -8.57% | 8.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 151.73% | -296.50% | |||
| Total Operating Expenses | 1.60% | -3.43% | |||
| Operating Income | -21.47% | 11.90% | |||
| Income Before Tax | 16.52% | -24.70% | |||
| Income Tax Expenses | 53.72% | -41.24% | |||
| Earnings from Continuing Operations | 8.74% | -20.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1.28% | 3.04% | |||
| Net Income | 8.79% | -20.06% | |||
| EBIT | -21.47% | 11.90% | |||
| EBITDA | -10.47% | 2.35% | |||
| EPS Basic | 8.76% | -20.03% | |||
| Normalized Basic EPS | -29.90% | 25.11% | |||
| EPS Diluted | 8.76% | -20.03% | |||
| Normalized Diluted EPS | -29.90% | 25.11% | |||
| Average Basic Shares Outstanding | 0.03% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.03% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||